Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.77 USD
−6.28 M USD
39.55 M USD
2.28 M
About Cumberland Pharmaceuticals Inc.
Sector
CEO
A. J. Kazimi
Headquarters
Nashville
Website
Founded
1999
FIGI
BBG000R93GV7
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CPIX is 1.08 USD — it has decreased by −1.80% in the past 24 hours. Watch Cumberland Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cumberland Pharmaceuticals Inc. stocks are traded under the ticker CPIX.
CPIX stock has fallen by −9.17% compared to the previous week, the month change is a −12.80% fall, over the last year Cumberland Pharmaceuticals Inc. has showed a −37.57% decrease.
CPIX reached its all-time high on Aug 11, 2009 with the price of 17.75 USD, and its all-time low was 1.07 USD and was reached on Nov 1, 2024. View more price dynamics on CPIX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CPIX stock is 7.61% volatile and has beta coefficient of 0.43. Track Cumberland Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Cumberland Pharmaceuticals Inc. there?
Today Cumberland Pharmaceuticals Inc. has the market capitalization of 15.31 M, it has decreased by −9.17% over the last week.
Yes, you can track Cumberland Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Cumberland Pharmaceuticals Inc. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
CPIX net income for the last quarter is −1.54 M USD, while the quarter before that showed −1.09 M USD of net income which accounts for −42.23% change. Track more Cumberland Pharmaceuticals Inc. financial stats to get the full picture.
No, CPIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 91.00 employees. See our rating of the largest employees — is Cumberland Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cumberland Pharmaceuticals Inc. EBITDA is −1.29 M USD, and current EBITDA margin is −1.80%. See more stats in Cumberland Pharmaceuticals Inc. financial statements.
Like other stocks, CPIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cumberland Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cumberland Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cumberland Pharmaceuticals Inc. stock shows the strong sell signal. See more of Cumberland Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.